可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina)[J]. J Am Coll Cardio, 2000, 36(3):970 -1062.
[2] Garber AJ. Attenuating cardiovascular risk factors in patients with type 2 diabetes[J]. Am Fam Physician, 2000, 62(12):2633-2645.
[3] Ross R. Atherosclerosis: an in flammatory disease[J]. N Engl J Med, 1999, 340(2):115-126.
[4] Libby P, Ridker P, Maseri A. Inflammation and atherosclerosis[J]. Circulation, 2002, 105(9):1135-1143.
[5] Du Clos TW. Function of C2reactive protein[J]. Ann Med, 2000, 32(4):274-278.
[6] Schwartz RS, Bayes-Genis A, Lesser JR, et al. Detecting vulnerable plaque using peripheral blood:inflammatory and cellular markers[J]. J Interv Cardiol, 2003, 16(3):231-242.
[7] Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular disease[J]. Med Hypotheses, 2004, 62(4):499-506.
[8] Wang ND, Pio J, Valencia R. Distribution of C-reactive protein and its relation to risk factors and coronary heart disease risk estimation in the Nationl Health and Nutrion Examination Survey (NHANES) Ⅲ[J]. Prev Cardiol, 2001, 4(3):109-114.
[9] Luc G, Arveiler D, Evans A, et al. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and incient coronary heart disease: The PRIME study[J]. Atherosclerosis, 2003, 170(1):169-176.